162 related articles for article (PubMed ID: 37223323)
1. Beta 2-microglobulin: case report of a rare cause of cardiac amyloidosis.
Haslett JJ; Patel JK; Kittleson MM
Eur Heart J Case Rep; 2023 May; 7(5):ytad239. PubMed ID: 37223323
[TBL] [Abstract][Full Text] [Related]
2. A Case of Wild-type Cardiac Transthyretin Amyloidosis Diagnosed by Non-invasive Methods.
Lizarazo Ortega DA; Valderrama BP; González-Robledo G; Trujillo PB
Curr Med Imaging; 2023; 19(4):402-406. PubMed ID: 35692154
[TBL] [Abstract][Full Text] [Related]
3. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of variant-type transthyretin and immunoglobulin light-chain amyloidosis: a case report.
Eda Y; Ishii S; Onagi S; Katoh N; Ako J
Eur Heart J Case Rep; 2024 Jun; 8(6):ytae264. PubMed ID: 38872953
[TBL] [Abstract][Full Text] [Related]
5. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
6. False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report.
Zeng Y; Poterucha TJ; Einstein AJ; Zhang Q; Chen Y; Xie H; Wan K; Liang Y; Chen J; Tang G
Medicine (Baltimore); 2021 Apr; 100(17):e25582. PubMed ID: 33907108
[TBL] [Abstract][Full Text] [Related]
7. Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio.
Zach D; Ablasser K; Kolesnik E; Hoeller V; Fruhwald F; Prüller F; Reiter C; Beham-Schmid C; Lipp R; Rainer PP; Zirlik A; Wölfler A; Verheyen N
ESC Heart Fail; 2021 Aug; 8(4):3397-3402. PubMed ID: 33960730
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
[TBL] [Abstract][Full Text] [Related]
9. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
[TBL] [Abstract][Full Text] [Related]
10. Case Report and Literature Review of Cardiac Amyloidosis: A Not-So-Rare Cause of Heart Failure.
Baptista P; Moura de Azevedo S; Alexandre A; Dias-Frias A
Cureus; 2023 Jan; 15(1):e33364. PubMed ID: 36751253
[TBL] [Abstract][Full Text] [Related]
11. A case of cardiac amyloidosis incidentally detected by bone scintigraphy.
Tanaka H; Hosono M; Kanagaki M; Shimizu M; Matsubara N; Kawabata K; Miyamoto T; Itoi K
Asia Ocean J Nucl Med Biol; 2021; 9(1):71-75. PubMed ID: 33392354
[TBL] [Abstract][Full Text] [Related]
12. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
13. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
[TBL] [Abstract][Full Text] [Related]
14. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
Fine NM; Davis MK; Anderson K; Delgado DH; Giraldeau G; Kitchlu A; Massie R; Narayan J; Swiggum E; Venner CP; Ducharme A; Galant NJ; Hahn C; Howlett JG; Mielniczuk L; Parent MC; Reece D; Royal V; Toma M; Virani SA; Zieroth S
Can J Cardiol; 2020 Mar; 36(3):322-334. PubMed ID: 32145862
[TBL] [Abstract][Full Text] [Related]
15. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
Manolis AS; Manolis AA; Manolis TA; Melita H
Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
[TBL] [Abstract][Full Text] [Related]
16. Challenges and Strategies in the Diagnosis of Cardiac Amyloidosis.
Fine NM
Can J Cardiol; 2020 Mar; 36(3):441-443. PubMed ID: 31964561
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).
Yilmaz A; Bauersachs J; Bengel F; Büchel R; Kindermann I; Klingel K; Knebel F; Meder B; Morbach C; Nagel E; Schulze-Bahr E; Aus dem Siepen F; Frey N
Clin Res Cardiol; 2021 Apr; 110(4):479-506. PubMed ID: 33459839
[TBL] [Abstract][Full Text] [Related]
18. A case report of isolated cardiac light chain amyloidosis without clinically overt heart failure: an under-recognized presentation.
Nuzzi V; Porcari A; Gigli M; Zaja F; Dore F; Bussani R; Sinagra G; Merlo M
Eur Heart J Case Rep; 2023 Mar; 7(3):ytad072. PubMed ID: 36909839
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
[TBL] [Abstract][Full Text] [Related]
20. Heavy and light chain (AHL)-type cardiac amyloidosis: first histopathologic-proven case illustrating involvement of the heart.
Sekulic M; Pichler Sekulic S; Weins A
Virchows Arch; 2020 Nov; 477(5):733-738. PubMed ID: 32388718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
